[Editor's Note: This article was originally published in October 2013 but has been updated for accuracy and comprehensiveness.]

Women are roughly three times more likely than men to experience migraines, about 17% of women versus 6% of men in the U.S. The main driver is the interaction between the hormone estrogen and a pain-signaling protein called CGRP: when estrogen drops or fluctuates, CGRP activity rises and the brain's threshold for a migraine attack falls.

That's the short answer. The longer answer involves genetics, brain biology, and the hormonal transitions of a woman's life. It explains why migraine patterns often change at puberty, during pregnancy, and through perimenopause. Here's what the current research shows, and what it means for getting effective treatment.

Key Takeaways

• Migraine affects about 1 in 5 women, and women's lifetime cumulative incidence is roughly 43%. Nearly one in two women will experience migraine at some point.
• Migraine is the leading cause of years lived with disability in women under 50.
• Fluctuating estrogen, not simply "having hormones," is the core biological driver. Sharp estrogen drops trigger a surge in CGRP, the same protein targeted by today's most effective migraine medications.
• In late 2025, the American Headache Society issued a position statement recommending annual migraine screening for adolescent girls and women at routine healthcare visits, because migraine in women remains significantly underdiagnosed and undertreated.
• Effective, targeted treatments now exist for every hormonal life stage,  menstruation, pregnancy planning, perimenopause, and beyond.

How Much More Common Are Migraines in Women?

The gender gap in migraine is one of the most consistent findings in neurology:

• Before puberty, boys and girls experience migraines at similar rates.
• After puberty, prevalence in girls climbs steeply. By adulthood, women are about three times more likely than men to have migraine.
• Roughly 17% of U.S. women experience migraine each year, compared with about 6% of men.
• Women's attacks also tend to last longer, occur more frequently, and come with more associated symptoms, nausea, light sensitivity, and sound sensitivity, than men's.

The timing is the biggest clue. Because the gap opens at puberty, narrows in some women during pregnancy, and often (though not always) closes after menopause, researchers have long suspected sex hormones, and modern research has confirmed the mechanism.

What Role Does Estrogen Play in Migraines?

Estrogen doesn't cause migraines by itself. The problem is change, specifically, sharp drops or unpredictable swings in estrogen levels.

This idea, known as the estrogen withdrawal hypothesis, dates back to the early 1970s, and decades of research since have refined it. The pattern researchers see over and over:

• High, stable estrogen is protective. Many women experience dramatic migraine relief during the second and third trimesters of pregnancy, when estrogen is elevated and steady.
• Falling estrogen lowers the attack threshold. The days just before and during menstruation, when estrogen drops sharply, are the highest-risk window of the month. This is why so many women experience "menstrual migraines."
• Fluctuating estrogen is destabilizing. Perimenopause, when hormone levels swing unpredictably, is often the worst period for migraine frequency in a woman's life.

Estrogen receptors are found throughout the trigeminovascular system (the network of nerves and blood vessels responsible for migraine pain) which is why the brain's pain pathways are so responsive to hormonal shifts. Estrogen also modulates key neurotransmitters involved in pain processing, including serotonin and GABA.

The CGRP Connection: Why This Research Matters for Treatment

The most important advance in understanding the estrogen–migraine link involves CGRP (calcitonin gene-related peptide), a protein released by the trigeminal nerve that transmits pain signals and drives the inflammation behind migraine attacks.

Here's how the pieces fit together:

1. Stable estrogen suppresses CGRP activity. When estrogen falls or fluctuates, CGRP release increases, lowering the threshold for an attack.
2. Women have higher circulating CGRP levels than men. This is a consistent research finding that helps explain the prevalence gap at a biological level.
3. CGRP levels rise during menstruation in women with migraine, but notably, not in women without migraine, even though both groups experience the same hormonal cycle. Migraine brains appear uniquely sensitive to this hormonal-CGRP cascade.

This isn't just academic. CGRP is the target of the newest generation of migraine treatments, anti-CGRP monoclonal antibodies and gepants, which the American Headache Society now recommends as first-line preventive options. Understanding that your migraines are hormonally driven doesn't mean you have to wait them out; it means there are treatments designed for exactly this mechanism.

How Migraines Change Through a Woman's Life

Migraine doesn't stay static. In fact, research tracking migraine across a woman's life shows the pattern shifting at each major hormonal transition, from the first period through the years after menopause. 

Puberty and Adolescence

Migraine incidence in girls rises sharply once menstrual cycles begin. Unfortunately, this is also when migraines are most likely to be dismissed as "just headaches" or stress, one reason new screening guidelines specifically include adolescent girls.

Menstruation

Menstrual migraine, attacks that reliably occur in the window from about two days before through three days after the start of a period, affects a large share of women with migraine. These attacks tend to be longer, more severe, and more resistant to treatment than attacks at other times of the month. Targeted strategies exist, including short-term "mini-prevention" around the menstrual window.

Pregnancy

Many women improve significantly during pregnancy, especially in the second and third trimesters, thanks to high, stable estrogen. However, migraine treatment during pregnancy requires careful planning, since many medications aren't recommended, a conversation worth having with a specialist before trying to conceive.

Perimenopause

The years leading up to menopause often bring a temporary worsening of migraine as estrogen levels swing erratically. Sleep disruption and hot flashes can compound the problem.

Menopause and Beyond

Migraines often improve after menopause, once hormones stabilize at a lower level, but relief isn't guaranteed. According to a 2025 study of about 5,000 women, as many as 46% of women in the study continued having migraine attacks after they had passed menopause. If you were told menopause would cure your migraines and it hasn't, you're not an outlier. And, don't worry, you still have treatment options.

What About Hormonal Birth Control?

Hormonal contraceptives affect every woman differently. Some find that steady hormone dosing smooths out their cycle-related attacks; others find their migraines worsen, classically during the placebo week, when the sudden estrogen drop can trigger an attack.

Two important safety notes:

• Women who have migraine with aura need an individualized risk discussion before using estrogen-containing contraception, because research shows stroke risk depends on estrogen dose and aura frequency.
• If your migraines changed after starting or stopping birth control, tell your doctor. That pattern is diagnostically useful and may point toward simple adjustments (such as continuous-dosing regimens that eliminate the monthly estrogen drop).
  
  

Is It Only Hormones? Other Reasons Women Are Hit Harder

Hormones are the biggest factor, but not the only one:

• Genetics. Migraine runs strongly in families, and some genetic factors appear to interact with sex-specific biology.
• Brain differences. Imaging research suggests women's brains may process pain signals differently, with greater susceptibility to the "central sensitization" that makes migraines chronic and touch-sensitive over time.
• Underdiagnosis and undertreatment. Women's pain is more likely to be minimized in healthcare settings, and many women manage debilitating attacks for years before receiving a migraine diagnosis, which delays access to effective treatment and can allow episodic migraine to become chronic.

New in 2026: Doctors Are Now Urged to Screen All Women for Migraine

In a position statement published in Headache, the American Headache Society formally recommended that all adolescent girls and women be screened for migraine annually as part of routine preventive care, from adolescence through menopause, the years when prevalence peaks.

Why such a sweeping recommendation? Because the numbers justify it:

• Migraine's lifetime cumulative incidence in women is about 43%
• It is the leading cause of years lived with disability in women under 50
• Validated screening takes minutes . The ID Migraine screener is just three questions
• Effective treatments exist, but only help people who are actually diagnosed

The practical takeaway: you don't have to wait for a doctor to ask. If you experience recurring headaches with nausea, light sensitivity, or that limit your activities, ask directly: "Could this be migraine?" One in five women have it. Most were never formally diagnosed.

When Should You See a Specialist?

Consider an evaluation with a migraine specialist if:

• Your headaches follow your menstrual cycle
• Attacks are becoming more frequent or more severe (especially during perimenopause)
• Over-the-counter medication isn't working, or you need it more than 2–3 days per week
• Migraines are interfering with work, family, or daily activities
• Your migraine pattern changed with pregnancy, birth control, or menopause
• You've never had a formal diagnosis despite years of recurring headaches

Hormonal migraines are among the most treatable forms of migraine, with options ranging from CGRP-targeting medications and menstrual mini-prevention protocols to Botox®, hormonal strategies, and lifestyle-based trigger management. The specialists at the Migraine Relief Center can help identify your specific pattern and build a treatment plan around it. Schedule an evaluation with our team today.

Frequently Asked Questions

Why do women get more migraines than men?

Women get more migraines primarily because of the interaction between estrogen and CGRP, a pain-signaling protein. When estrogen levels drop or fluctuate, as they do before menstruation, postpartum, and during perimenopause, CGRP activity increases and the brain's threshold for a migraine attack falls. Women also have higher baseline CGRP levels than men.

How many women have migraines?

About 17% of women in the U.S. experience migraine each year, compared with roughly 6% of men, approximately a 3-to-1 ratio. Across a lifetime, about 43% of women will experience migraine at some point.

What is a menstrual migraine?

A menstrual migraine is an attack that occurs in the window from about two days before through three days after the start of a period, triggered by the natural drop in estrogen. These attacks are often longer, more severe, and harder to treat than migraines at other times of the month, but targeted prevention strategies exist.

Do migraines go away after menopause?

Often, but not always. Migraines frequently improve once hormones stabilize after menopause, but a 2025 study of nearly 5,000 women found 46% continued having attacks post-menopause, and about 1 in 5 still had attacks after age 60. Perimenopause, the transition years, is often when migraines temporarily worsen.

Can birth control help or hurt migraines?

Both, depending on the person. Steady hormone dosing helps some women by smoothing out estrogen fluctuations, while others experience worse attacks, especially during the placebo week when estrogen drops. Women who have migraine with aura should discuss stroke risk with their doctor before using estrogen-containing contraception.

Is there a test to diagnose migraine?

There's no blood test or scan, but diagnosis is straightforward with a validated screening questionnaire and clinical evaluation. The American Headache Society now recommends annual migraine screening for adolescent girls and women at routine healthcare visits using tools like the three-question ID Migraine screener.